Wedbush Maintains Neutral on Healthcare Realty Trust, Raises Price Target to $16
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Richard Anderson has maintained a Neutral rating on Healthcare Realty Trust (NYSE:HR) and raised the price target from $15 to $16.
May 08, 2024 | 1:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wedbush has maintained a Neutral rating on Healthcare Realty Trust and increased the price target from $15 to $16.
The increase in price target by Wedbush suggests a positive adjustment in the valuation of Healthcare Realty Trust, potentially leading to increased investor interest and a positive short-term price movement. However, the Neutral rating indicates that the analyst sees the stock as fairly valued at its current price, balancing the potential for both upside and downside.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 90